Ardelyx, Inc. Profile Avatar - Palmy Investing

Ardelyx, Inc.

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which h…

Biotechnology
US, Waltham [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Ardelyx, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ARDX's Analysis
CIK: 1437402 CUSIP: 039697107 ISIN: US0396971071 LEI: - UEI: -
Secondary Listings
ARDX has no secondary listings inside our databases.